CHARLOTTESVILLE, Va., Aug 14 (Reuters) – The chief executive
of one of the world’s largest pharmaceutical companies resigned
on Monday from a business panel led by Donald Trump, citing a
need for leadership countering bigotry in a strong rebuke to the
U.S. president over his response to a violent white-nationalist
rally in Virginia.